Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation

摘要

AIMSTo examine whether CYP3A4-metabolizing statin use modified the association between clopidogrel use and major adverse cardiovascular events (MACE) after coronary stent implantation, using time-varying drug exposure ascertainment.